Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H9KW
|
||||
Former ID |
DNC002668
|
||||
Drug Name |
Filaminast
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Discontinued in Phase 2 | [545618] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H20N2O4
|
||||
Canonical SMILES |
CC(=NOC(=O)N)C1=CC(=C(C=C1)OC)OC2CCCC2
|
||||
InChI |
1S/C15H20N2O4/c1-10(17-21-15(16)18)11-7-8-13(19-2)14(9-11)20-12-5-3-4-6-12/h7-9,12H,3-6H2,1-2H3,(H2,16,18)/b17-10+
|
||||
InChIKey |
STTRYQAGHGJXJJ-LICLKQGHSA-N
|
||||
CAS Number |
CAS 141184-34-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [551393] | |
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.